International VWD guidelines and how to use them

Details

Year: 2020

Language: English

Author(s): World Federation of Hemophilia

Date: November 20, 2020

Access Webinar

Additional Information

Listen to this 75-minute webinar, presented on November 20, 2020 at the World Federation of Hemophilia (WFH) Global Summit on Women & Girls with Inherited Bleeding Disorders, to learn more about how the ASH ISTH NHF ISTH WFH 2021 VWD Guidelines can be used for advocacy in ensuring adequate treatment and care for persons living with VWD.

Magdy El Ekiaby (Hematologist), Abira Maheen (Person with VWD and Joint Secretary, Hemophilia Foundation-Pakistan), Paula James (Hematologist), Susie Couper (Person with VWD and Parent of a person with VWD), and Claudia Djambas Khayat (Hematologist) discuss the international VWD Guidelines for the bleeding disorder community patients and healthcare professionals alike.

The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Related Resources